Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease.

Arquivos de neuro-psiquiatria - 1 Apr 2020

Santos-Lobato Bruno Lopes, Schumacher-Schuh Artur F, Rieder Carlos R M, Hutz Mara H, Borges Vanderci, Ferraz Henrique Ballalai, Mata Ignacio F, Zabetian Cyrus P, Tumas Vitor

Abstract excerpt

BACKGROUND: There are currently no methods to predict the development of levodopa-induced dyskinesia (LID), a frequent complication of Parkinson's disease (PD) treatment. Clinical predictors and single nucleotide polymorphisms (SNP) have been associated to LID in PD. OBJECTIVE: To investigate the association of clinical and genetic variables with LID and to develop a diagnostic prediction model for LID in PD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Dopamine Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyskinesia, Drug-Induced

Share to Levodopa

Share to Parkinson Disease

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 32294749
DOI: 10.1590/0004-282X20190191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease.PMID 32294749Read ↗

Dopamine pathway and Parkinson’s risk variants are associated with levodopa-induced dyskinesiaSemantic proximity Read ↗

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s diseaseSemantic proximity Read ↗

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.Semantic proximity Read ↗

Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.Semantic proximity Read ↗

EPIDEMIOLOGY OF LEVODOPA-INDUCED DYSKINESIA: PREVALENCE AND ASSOCIATED CLINICAL FACTORS IN LATIN AMERICASemantic proximity Read ↗

Prediction of impulse control disorders in Parkinson’s disease: a longitudinal machine learning studySemantic proximity Read ↗

Exome-wide association study of levodopa-induced dyskinesia in Parkinson's disease.Semantic proximity Read ↗

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.Semantic proximity Read ↗

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.Semantic proximity Read ↗

Associations between variants in levodopa metabolic pathway genes and levodopa-induced dyskinesia in Parkinson's disease.Semantic proximity Read ↗

Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.Semantic proximity Read ↗

Genetic prediction of impulse control disorders in Parkinson's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.